查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945112

全球医药包衣市场（按产品类型、聚合物类型、给药途径、应用和最终用户划分）预测（2026-2032）

Pharmaceutical Coating Market by Product Type, Polymer Type, Route Of Administration, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，药品涂层市场价值将达到 45 亿美元，到 2026 年将成长至 48.1 亿美元，到 2032 年将达到 71.9 亿美元，复合年增长率为 6.92%。

关键市场统计数据
基准年 2025 45亿美元
预计年份：2026年 48.1亿美元
预测年份 2032 71.9亿美元
复合年增长率 (%) 6.92%

本文简要概述了药物包衣的基本原理、市场驱动因素、法规环境以及影响近期业务决策的策略重点。

药物包衣领域是药物製剂科学与商业产品供应的关键交会点，它整合了材料科学、法规遵循和生产实践。本文概述了该领域的核心功能，重点阐述了包衣如何影响药物的稳定性、生物利用度、患者接受度和供应链的稳健性。随着产业的不断发展，包覆的选择对产品差异化和生命週期策略的影响日益显着。因此，经营团队必须了解製剂成分、生产限制和最终用户期望之间的相互作用。

技术创新、永续性需求和供应链重组如何改变药物包衣的配方和交付方式

技术进步、监管机构对品质源于设计 (QbD) 的重视以及相关人员对永续性的压力，正共同推动药物包衣配方和生产流程的变革。聚合物化学和包衣设备的进步使得对包衣厚度和释放曲线的精确控製成为可能，而数位化监控和製程分析技术则为以往难以实现的大规模包衣製程带来了一致性。同时，功能性包衣（例如缓释和掩味系统）的创新，正在拓展配方选择，并使产品团队能够以更低的风险追求差异化的给药方案。

评估美国关税和贸易政策变化在2025年对营运、定价和合规方面的累积影响

美国在2025年推出的政策转变和关税措施将对医药涂料价值链的投入成本、采购选择和合约结构带来特定压力。不断上升的关税壁垒可能会增加进口聚合物和特殊添加剂的到岸成本，迫使采购团队重新审视其供应商组合、重新谈判合约条款并考虑近岸外包方案。为此，一些製造商可能会选择增加库存缓衝或优先签订长期供应协议，以稳定供应并降低价格波动。

按产品类型、聚合物化学、应用、给药途径和最终用户管道细分细分市场层面的机会和绩效指标

详细的市场細項分析揭示了配方选择、聚合物化学和终端用户管道如何与生产限制和监管要求相互交织。按产品类型划分，市场分析涵盖了压片包衣、薄膜包衣、聚合物包衣和糖衣，每种产品路线都对製程控制和分析提出了独特的要求。压片包衣需要精确的片剂压制和层间黏合力的控制，而薄膜包衣则强调聚合物分散的均匀性和涂覆过程中溶剂的处理。聚合物包衣具有可调的功能，但需要进行相容性测试，而糖衣是一种传统的选择，具有装饰性和掩味作用。

美洲、欧洲、中东和非洲以及亚太市场存在明显的区域策略差异和需求因素，这些差异和因素对业务营运产生影响。

区域趋势对原料供应、法规要求和首选服务模式有显着影响。在美洲，供应链韧性和监管协调工作往往侧重于合规文件、本地品质审核，并优先考虑能够展现快速反应能力的供应商。该地区通常需要可扩展的解决方案，并具备快速商业化週期和完善的监管路径。

竞争动态、创新模式、伙伴关係模式和製造趋势正在塑造製药涂料行业的公司策略定位。

公司层面的策略呈现出围绕着创新、整合和服务专业化的清晰差异化模式。主要企业正投资于配方科学、专有聚合物系统和自动化包衣平台，以缩短生产週期并提高产品可重复性。其他企业则透过契约製造客户提供包括配方支援、製程验证和供应链保障在内的综合服务来实现差异化竞争。

为行业领导者提供可操作的优先事项和战术性步骤，以增强韧性、加速创新并优化涂料价值链的采购。

产业领导者应立即采取切实可行的措施，增强韧性，加速创新，并优化整个涂料价值链的采购流程。首先，从配方开发的早期阶段就整合跨职能团队（包括采购、法规事务、研发和生产部门），确保材料选择符合营运限制和核准途径。这可以减少返工，加快产品上市速度，并从一开始就将品质因素纳入考虑。其次，透过寻找替代供应商和製定策略性库存政策，实现筹资策略多元化。严格的供应商审核和材料特性分析程序可以降低风险，减少供应中断的可能性。

一种透明且可复製的调查方法，结合了初步访谈、技术文献综述、监管扫描和供应链检验技术。

本分析所依据的研究采用了混合方法，强调透明度、可重复性和实际相关性。主要研究包括与配方科学家、品管人员、采购经理和契约製造製造商进行结构化访谈和技术咨询，以了解实际应用中的限制因素和决策标准。次要研究涵盖了同行评审文献、监管指导文件、安全资料表和设备技术规范，检验技术声明并阐明製程要求。

本文简要总结了战略意义、新兴风险和现有机会，旨在为药物包衣计画的经营团队重点提供参考。

总之，药物包衣是一个具有重要策略意义的领域，它将製剂性能与商业性成果、监管核准和病患体验紧密联繫起来。聚合物化学、包覆技术、供应链韧性和区域监管要求之间的相互作用决定了包覆策略的可行性和竞争力。对聚合物选择、製程分析控制和供应商透明度的策略性投资可以显着降低营运波动，并有助于更顺畅的监管流程。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的药品包衣市场

  • 压缩涂层
  • 薄膜涂层
  • 聚合物涂层
  • 糖霜

9. 依聚合物类型分類的药物包衣市场

  • 天然聚合物
    • 明胶
    • 虫胶
    • 淀粉
  • 合成聚合物
    • 丙烯酸酯
    • 纤维素醚
    • 甲基丙烯酸酯

10. 依给药途径分類的药物包衣市场

  • 口服
  • 肠外
    • 肌肉内注射
    • 静脉注射
  • 外用

第十一章 依应用分類的药品包衣市场

  • 胶囊
  • 颗粒
  • 颗粒
  • 药片

第十二章 依最终用户分類的药品包衣市场

  • 契约製造
  • 医院和诊所
    • 诊所
    • 医院
  • 製药公司

第十三章：依地区分類的药品包衣市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 药品包衣市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国药品包衣市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国药品包衣市场

第十七章：中国药品包衣市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ACG Pharmapack
  • Air Liquide SA
  • Aristocrat Instruments
  • Ashland Global Holdings, Inc.
  • Balchem Corporation
  • BASF SE
  • Biogrund GmbH
  • Biogrund GmbH
  • Coating Place, Inc.
  • Colorcon, Inc.
  • Croda International Plc
  • Eastman Chemical Company
  • Evonik Industries AG
  • FMC Corporation
  • Gattefosse
  • IHSAN Sons（Pvt）Ltd.
  • Kerry Group plc
  • Microchem Srl
  • Pharmachem Laboratories, Inc.
  • Roquette Freres
  • Sensient Technologies Corporation
  • The Dow Chemical Company
  • The Lubrizol Corporation
  • Vikram Thermo（India）Limited
  • Wacker Chemie AG
Product Code: MRR-8D2A80511E8B

The Pharmaceutical Coating Market was valued at USD 4.50 billion in 2025 and is projected to grow to USD 4.81 billion in 2026, with a CAGR of 6.92%, reaching USD 7.19 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.50 billion
Estimated Year [2026] USD 4.81 billion
Forecast Year [2032] USD 7.19 billion
CAGR (%) 6.92%

A concise orientation to pharmaceutical coating fundamentals, market drivers, regulatory dynamics, and strategic priorities shaping near-term executive decisions

The pharmaceutical coating sector represents a vital interface between drug formulation science and commercial product delivery, integrating materials science, regulatory compliance, and manufacturing practice. This introduction outlines the domain's core functional roles, emphasizing how coatings modulate stability, bioavailability, patient acceptability, and supply chain robustness. As the industry evolves, coating choices increasingly influence product differentiation and lifecycle strategy; therefore, executives must understand the interplay among formulation components, production constraints, and end-user expectations.

Emerging regulatory scrutiny and heightened quality standards have pushed coating development toward more reproducible, analytically verifiable systems. Consequently, development teams are prioritizing polymer selection, coating process control, and in-line analytical tools to reduce batch variability. At the same time, commercial stakeholders are balancing cost, sustainability, and intellectual property considerations when deciding between in-house formulation versus outsourced coating services. Taken together, these dynamics frame the essential context for subsequent analysis, and set the stage for practical decisions that reconcile scientific objectives with operational realities.

How technological advances, sustainability mandates, and supply chain reconfiguration are driving transformative shifts across pharmaceutical coating formulation and delivery

Technological progress, regulatory emphasis on quality by design, and stakeholder pressure for sustainability are collectively catalyzing transformative shifts across pharmaceutical coating formulation and manufacturing. Advances in polymer chemistry and coating equipment are enabling finer control of film thickness and release profiles, while digital monitoring and process analytical technologies bring previously elusive consistency to large-scale coating operations. At the same time, innovation in functional coatings-such as modified-release and taste-masking systems-expands formulation choices and allows product teams to pursue differentiated delivery profiles with lower risk.

Supply chain realignments and geopolitical considerations are also reshaping strategic priorities. Manufacturers are increasingly evaluating dual-sourcing models, regional manufacturing nodes, and closer integration with polymer suppliers to mitigate disruption risk. Regulatory authorities continue to strengthen expectations around traceability and material characterization, which forces greater transparency upstream in polymer production and downstream in contract manufacture relationships. Sustainability mandates further influence decision-making, encouraging a shift toward biodegradable excipients and solventless coating processes where feasible. In combination, these factors are prompting more cross-functional collaboration among R&D, regulatory affairs, procurement, and commercial teams, thereby accelerating adoption of integrated development practices and smarter sourcing strategies.

Assessing the cumulative operational, pricing, and compliance impacts arising from evolving United States tariff measures and trade policy changes in 2025

Policy shifts and tariff measures instituted by the United States in 2025 introduce tangible pressures on input costs, sourcing choices, and contractual arrangements across the pharmaceutical coating value chain. Rising tariff barriers can increase landed costs for imported polymers and specialty excipients, prompting procurement teams to revisit supplier portfolios, renegotiate terms, and consider nearshoring options. In response, some manufacturers may opt to increase inventory buffers or prioritize long-term supplier contracts to stabilize supply and pricing volatility.

Operational implications extend beyond raw material pricing. Tariff-induced cost escalation can accelerate vertical integration strategies as downstream firms seek to capture more of the value chain and reduce exposure to cross-border duties. Moreover, manufacturing footprints may shift as companies evaluate the trade-offs between higher domestic production costs and the risks associated with international logistics and customs complexity. Regulatory compliance can become more complex when inputs cross additional jurisdictions, increasing documentation burdens and the need for validated supply chain audits.

From a commercial perspective, corporations must weigh the potential for margin compression against strategic opportunities to differentiate through localized supply reliability and faster lead times. Contract manufacturers and service providers face particular pressure to demonstrate resilient sourcing strategies and to offer transparent pass-through cost mechanisms. Ultimately, proactive scenario planning and enhanced supplier collaboration will be critical to managing the cumulative effects of tariff changes while preserving product quality and manufacturing continuity.

Deconstructing segment-level opportunities and performance indicators across product types, polymer chemistries, applications, administration routes, and end-user channels

A granular view of segmentation clarifies how formulation choices, polymer chemistries, and end-user channels intersect with manufacturing and regulatory constraints. Based on Product Type, market is studied across Compression Coating, Film Coating, Polymer Coating, and Sugar Coating, and each product pathway imposes distinct process control and analytical requirements. Compression coating demands precise tablet compaction and layer adhesion control, whereas film coating emphasizes uniformity of polymer dispersion and solvent handling during application. Polymer-based coatings offer functional tunability but require compatibility testing, and sugar coatings present legacy options with particular decorative and taste-masking attributes.

Based on Polymer Type, market is studied across Natural Polymers and Synthetic Polymers. The Natural Polymers is further studied across Gelatin, Shellac, and Starch. The Synthetic Polymers is further studied across Acrylates, Cellulose Ethers, and Methacrylates. Each polymer class carries a different risk profile in terms of batch-to-batch variability, regulatory familiarity, and environmental footprint, which constrains selection in regulated product dossiers. Based on Application, market is studied across Capsules, Granules, Pellets, and Tablets; application form influences coating thickness, adhesion properties, and coating equipment selection, as well as downstream dissolution testing strategies.

Based on Route Of Administration, market is studied across Oral, Parenteral, and Topical. The Parenteral is further studied across Intramuscular and Intravenous. Route of administration drives the highest standards for leachables, extractables, and sterility considerations, particularly when coatings interact with parenteral delivery systems. Based on End User, market is studied across Contract Manufacturers, Hospitals & Clinics, and Pharmaceutical Companies. The Hospitals & Clinics is further studied across Clinics and Hospitals. End users differ in procurement cycles, quality expectations, and tolerance for innovation, which in turn affects commercial strategies and service offerings across the coating ecosystem.

Regional strategic distinctions and demand drivers uncovered across Americas, Europe, Middle East and Africa, and Asia-Pacific markets with operational implications

Regional dynamics exert strong influence on raw material availability, regulatory expectations, and preferred service models. In the Americas, supply chain resilience and regulatory harmonization efforts tend to prioritize compliance documentation, localized quality audits, and a preference for suppliers that can demonstrate rapid response capabilities. This region often drives demand for scalable solutions that align with rapid commercialization timelines and well-established regulatory pathways.

Across Europe, Middle East & Africa, the landscape blends mature regulatory frameworks with diverse market access conditions. The region places premium value on sustainability credentials, solvent reduction, and adherence to rigorous environmental, health, and safety standards. Manufacturers operating here frequently invest in advanced process controls and green formulation approaches to meet both regulatory requirements and stakeholder expectations.

In the Asia-Pacific region, manufacturing scale, supplier diversity, and cost competitiveness coexist with rising expectations for quality assurance and regulatory maturation. Rapidly expanding pharmaceutical production hubs in this region are increasingly adopting sophisticated coating technologies, while contract manufacturing organizations compete on speed and flexibility. Taken together, regional distinctions suggest that a one-size-fits-all strategy will underperform; instead, optimized regional playbooks that align sourcing, compliance, and commercialization will yield superior operational outcomes.

Competitive dynamics, innovation patterns, partnership models, and manufacturing trends shaping company-level strategic positioning in pharmaceutical coatings

Company-level strategies reveal clear patterns of differentiation around innovation, integration, and service specialization. Leading organizations are investing in formulation science, proprietary polymer systems, and automated coating platforms to reduce cycle time and enhance product reproducibility. Others are differentiating through comprehensive service offerings that bundle formulation support, process validation, and supply chain guarantees for contract manufacturing clients.

Strategic partnerships between polymer suppliers, equipment manufacturers, and pharmaceutical developers are emerging as an effective way to accelerate time to market while sharing technical risk. Collaboration models frequently include co-development agreements, technical transfer arrangements, and joint quality assurance programs that align materials characterization with end-use performance. Additionally, firms that articulate clear sustainability roadmaps-such as solvent reduction targets, recyclable packaging, and life cycle analysis-are gaining traction with customers who prioritize environmental metrics alongside technical performance.

Operational excellence remains a critical axis of competition. Companies that standardize process analytical technologies, enforce robust change control, and maintain transparent supplier documentation are better positioned to support complex regulatory filings and to respond to customer demands for traceability. In sum, competitive advantage is increasingly tied to the ability to combine technical differentiation with reliable, auditable supply relationships and value-added services.

Actionable priorities and tactical measures for industry leaders to enhance resilience, accelerate innovation, and optimize sourcing across coating value chains

Industry leaders should take immediate, measurable steps to strengthen resilience, expedite innovation, and optimize sourcing across the coating value chain. First, integrate cross-functional teams that include procurement, regulatory affairs, R&D, and manufacturing early in formulation development to ensure material choices align with operational constraints and approval pathways. This reduces rework and shortens time to market while embedding quality considerations from the outset. Second, diversify sourcing strategies by qualifying alternative suppliers and establishing strategic inventory policies; rigorous supplier audits and material characterization programs will mitigate risk and reduce the probability of supply interruption.

Third, accelerate adoption of process analytical technologies and digital controls to improve reproducibility, lower failure rates, and provide defensible data for regulatory submissions. Fourth, pursue partnerships with polymer innovators and equipment providers to co-develop tailored coating solutions that balance functional performance with sustainability goals. Fifth, build scenario-based financial and operational models that incorporate tariff contingencies, logistics disruptions, and raw material shocks, thereby enabling rapid decision-making under uncertainty. Collectively, these measures create a robust operating posture that preserves product quality, protects margins, and enables strategic agility across changing market and policy environments.

Transparent and replicable research methodology combining primary interviews, technical literature review, regulatory scans, and supply chain validation techniques

The research underpinning this analysis employed a mixed-methods approach that emphasizes transparency, reproducibility, and practical relevance. Primary research included structured interviews and technical consultations with formulation scientists, quality leaders, procurement managers, and contract manufacturing executives to capture real-world constraints and decision criteria. Secondary research encompassed peer-reviewed literature, regulatory guidance documents, material safety data sheets, and equipment technical specifications to validate technical assertions and to contextualize process requirements.

Analytical procedures incorporated thematic synthesis of qualitative inputs, comparative assessment of polymer characteristics, and cross-validation of operational implications with supply chain data. Where appropriate, sensitivity analysis and scenario planning were used to examine the effects of policy shifts and supply disruptions on sourcing decisions and manufacturing resilience. Quality controls included triangulation of findings across independent sources and expert review by industry practitioners to ensure the interpretation of technical data was accurate and actionable. This methodological combination supports robust conclusions that align with both scientific rigor and commercial relevance.

Concise synthesis of strategic implications, emergent risks, and enduring opportunities that should guide executive agendas for pharmaceutical coating programs

In conclusion, pharmaceutical coating is a strategically important discipline that links formulation performance to commercial outcomes, regulatory acceptance, and patient experience. The interplay among polymer chemistry, coating technology, supply chain resilience, and regional regulatory expectations determines the feasibility and competitiveness of coating strategies. Strategic investments in polymer selection, process analytical control, and supplier transparency will materially reduce operational volatility and support smoother regulatory pathways.

Executives must prioritize integrated decision-making that meshes scientific objectives with procurement realities and market access demands. By doing so, organizations can mitigate the impact of external shocks, capture value through innovation, and respond rapidly to evolving customer and regulatory expectations. The synthesis presented here is designed to inform pragmatic action: adopt robust supplier qualification, embrace technological enablers that improve reproducibility, and align formulation choices with long-term sustainability and compliance goals. These measures will help organizations unlock the full potential of coating strategies while maintaining high standards of quality and patient safety.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Coating Market, by Product Type

  • 8.1. Compression Coating
  • 8.2. Film Coating
  • 8.3. Polymer Coating
  • 8.4. Sugar Coating

9. Pharmaceutical Coating Market, by Polymer Type

  • 9.1. Natural Polymers
    • 9.1.1. Gelatin
    • 9.1.2. Shellac
    • 9.1.3. Starch
  • 9.2. Synthetic Polymers
    • 9.2.1. Acrylates
    • 9.2.2. Cellulose Ethers
    • 9.2.3. Methacrylates

10. Pharmaceutical Coating Market, by Route Of Administration

  • 10.1. Oral
  • 10.2. Parenteral
    • 10.2.1. Intramuscular
    • 10.2.2. Intravenous
  • 10.3. Topical

11. Pharmaceutical Coating Market, by Application

  • 11.1. Capsules
  • 11.2. Granules
  • 11.3. Pellets
  • 11.4. Tablets

12. Pharmaceutical Coating Market, by End User

  • 12.1. Contract Manufacturers
  • 12.2. Hospitals & Clinics
    • 12.2.1. Clinics
    • 12.2.2. Hospitals
  • 12.3. Pharmaceutical Companies

13. Pharmaceutical Coating Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pharmaceutical Coating Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pharmaceutical Coating Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pharmaceutical Coating Market

17. China Pharmaceutical Coating Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ACG Pharmapack
  • 18.6. Air Liquide S.A.
  • 18.7. Aristocrat Instruments
  • 18.8. Ashland Global Holdings, Inc.
  • 18.9. Balchem Corporation
  • 18.10. BASF SE
  • 18.11. Biogrund GmbH
  • 18.12. Biogrund GmbH
  • 18.13. Coating Place, Inc.
  • 18.14. Colorcon, Inc.
  • 18.15. Croda International Plc
  • 18.16. Eastman Chemical Company
  • 18.17. Evonik Industries AG
  • 18.18. FMC Corporation
  • 18.19. Gattefosse
  • 18.20. IHSAN Sons (Pvt) Ltd.
  • 18.21. Kerry Group plc
  • 18.22. Microchem Srl
  • 18.23. Pharmachem Laboratories, Inc.
  • 18.24. Roquette Freres
  • 18.25. Sensient Technologies Corporation
  • 18.26. The Dow Chemical Company
  • 18.27. The Lubrizol Corporation
  • 18.28. Vikram Thermo (India) Limited
  • 18.29. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL COATING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICAL COATING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PHARMACEUTICAL COATING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY COMPRESSION COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY COMPRESSION COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY COMPRESSION COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY FILM COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY FILM COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY FILM COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SUGAR COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SUGAR COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SUGAR COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GELATIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GELATIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GELATIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SHELLAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SHELLAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SHELLAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY STARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY STARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY STARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ACRYLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ACRYLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ACRYLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CELLULOSE ETHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CELLULOSE ETHERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CELLULOSE ETHERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY METHACRYLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY METHACRYLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY METHACRYLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GRANULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GRANULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PELLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PELLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PELLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CONTRACT MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CONTRACT MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 181. GCC PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GCC PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 186. GCC PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 187. GCC PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 188. GCC PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. GCC PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. GCC PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 211. G7 PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. G7 PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 217. G7 PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 218. G7 PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. G7 PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. G7 PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 221. NATO PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. NATO PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. NATO PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 225. NATO PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 227. NATO PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 228. NATO PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. NATO PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. NATO PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL PHARMACEUTICAL COATING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA PHARMACEUTICAL COATING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY POLYMER TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY NATURAL POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA PHARMACEUTICAL COATING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)